Filing Details
- Accession Number:
- 0001181431-13-041165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-23 19:12:58
- Reporting Period:
- 2013-07-23
- Filing Date:
- 2013-07-23
- Accepted Time:
- 2013-07-23 19:12:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1302573 | Oncomed Pharmaceuticals Inc | OMED | Pharmaceutical Preparations (2834) | 383572512 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1162183 | Morgenthaler Partners Vii Lp | 2710 Sand Hill Road Menlo Park CA 94025 | No | No | Yes | No | |
| 1379550 | Morgenthaler Management Partners Vii, Llc | 2710 Sand Hill Road Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-23 | 710,526 | $0.00 | 710,526 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-23 | 834,732 | $0.00 | 1,545,258 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-23 | 893,825 | $0.00 | 2,439,083 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-07-23 | 70,588 | $17.00 | 2,509,671 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2013-07-23 | 710,526 | $0.00 | 710,526 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2013-07-23 | 834,732 | $0.00 | 834,732 | $0.00 |
| Common Stock | Series B-1 Preferred Stock | Disposition | 2013-07-23 | 893,825 | $0.00 | 893,825 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013.
- Morgenthaler Management Partners VII, L.L.C., as the general partner of Morgenthaler Partners VII, L.P., beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- The securities are immediately convertible.
- The expiration date is not relevant to the conversion of these securities.
Billionaire Hedge Funds
